Kalender
Berita
Pasar
Komoditas
Indeks
Saham
Mata Uang
Kripto
Obligasi
Indikator
Negara-negara
Prakiraan
Komoditas
Indeks
Mata Uang
Kripto
Obligasi
Negara-negara
Indikator
Kalender
Berita
Pasar
Komoditas
Indeks
Saham
Mata Uang
Kripto
Obligasi
Pendapatan
Liburan
Negara-negara
Amerika Serikat
Inggris Raya
Kawasan Euro
Australia
Kanada
Jepang
Tiongkok
Brazil
Rusia
India
Selanjutnya Negara-negara
Indikator
Tingkat Bunga
Tingkat Inflasi
Tingkat Pengangguran
Pertumbuhan PDB (q-to-q)
Pdb Per Kapita
Transaksi Berjalan
Cadangan Emas
Utang Pemerintah
Produksi Minyak Mentah
Harga Bensin
Peringkat Kredit
Selanjutnya Indikator
Prakiraan
Komoditas
Indeks
Mata Uang
Kripto
Obligasi
Negara-negara
Indikator
Apps
App Store
Google Play
Twitter
Akebia Therapeutics | AKBA - Kreditur Perdagangan
Keuangan
Harga Saham
USD
Aktiva
USD 362.52M
Kas Dan Setara
USD 162.64M
Biaya Penjualan
USD 10.34M
Aset Lancar
USD 243.48M
Kewajiban Lancar
USD 173.88M
UTANG
USD 46.51M
Dividen - Hasil
0
EBIT
USD -5.45M
EBITDA
USD 14.03M
Karyawan
167
Eps Laba Per Saham
USD -0.04
Modal Dan Cadangan
USD 27.38M
Laba Kotor Pada Penjualan
USD 47.28M
Beban Bunga Utang
362.52M
Modal Pinjaman
USD 36.4M
Kapitalisasi Pasar
USD 276.4M
Batas Pemasukan
USD -12.24M
Biaya Operasional
USD 63.08M
Laba Operasional
USD -5.45M
Modal Saham Biasa
USD 265.43M
Pe Harga Untuk Laba
1.63K
Laba Sebelum Pajak
USD -11.24M
Pendapatan Penjualan
USD 57.62M
Beban Penjualan Dan Administrasi
USD 23.53M
Saham
USD 13M
Kreditur Perdagangan
USD 8.39M
Debitur Perdagangan
USD 47.03M
Kreditur Perdagangan
Perubahan
Tanggal
Acadia Pharmaceuticals
USD 12.25M
1.34M
2026-03
Agios Pharmaceuticals
USD 16.34M
2.6M
2026-06
Akebia Therapeutics
USD 8.39M
12.8M
2026-03
Alnylam Pharmaceuticals
USD 108.02M
18.61M
2026-06
Amgen
USD 19.52B
1.37B
2026-03
Ardelyx
USD 28.2M
8.96M
2026-03
Astellas Pharma
JPY 199.75B
17.8B
2026-03
AstraZeneca
USD 22.89B
388M
2026-06
Bayer
EUR 6.59B
496M
2026-03
BioMarin Pharmaceutical
USD 793.15M
34.12M
2026-03
Celltrion
KRW 88.58B
9.9B
2026-03
Cspc Pharmaceutical
CNY 2.32B
236.83M
2025-12
Deva Holding AS
TRY 809.81M
105.88M
2023-09
Dianthus Therapeutics
USD 5.27M
4.45M
2026-03
Exelixis
USD 24.15M
5.47M
2026-03
Fresenius Medical Care
EUR 890.43M
54.88M
2026-03
GlaxoSmithKline
GBP 14.34B
7M
2026-06
Ionis Pharmaceuticals
USD 47.7M
21.67M
2026-06
Ironwood Pharmaceuticals
USD 3.24M
339K
2026-03
J&J
USD 9.22B
1.24B
2026-06
Kangmei Pharma
CNY 2.46B
153.5M
2026-03
Karyopharm Therapeutics
USD 4M
1.39M
2025-12
Knight Therapeutics
CAD 125.76M
7.63M
2025-12
Laboratorios Farma
EUR 107.59M
341K
2023-12
Lexicon Pharmaceuticals
USD 3M
87K
2026-03
Malin Corporation
EUR 700K
200K
2024-12
Medical Developments International
AUD 4.31M
2.18M
2025-12
Moderna
USD 167M
6M
2026-06
Nektar Therapeutics
USD 10.77M
4.79M
2025-12
Neuren Pharmaceuticals
AUD 2.4M
4.26M
2025-12
Organigram Holdings
CAD 73.14M
2.06M
2026-03
Ovoca Bio
EUR 186K
23K
2025-06
Pharma Mar
EUR 43.83M
10.51M
2026-03
Prothena
USD 4.3M
1.58M
2026-03
PTC Therapeutics
USD 40.45M
14.96M
2026-06
Qiagen NV
USD 78.3M
5.64M
2026-03
Regeneron Pharmaceuticals
USD 1.16B
132.2M
2026-06
Roche Holding
CHF 5.54B
237M
2026-06
Sanofi
EUR 23.6B
888M
2026-06
Sarepta Therapeutics
USD 70.38M
210.46M
2026-03
Sartorius
EUR 329.1M
16.2M
2026-06
Sino Biopharmaceutical
CNY 2.82B
1.32B
2025-06
Tectonic Therapeutic
USD 2.55M
1.46M
2026-03
Tilray
USD 114.5M
3.69M
2025-09
Vanda Pharmaceuticals
USD 39.09M
33.28M
2024-12
Zealand Pharma A/S
346.6M
102.71M
2025-12
Zz Pientze Pharmaceu
CNY 457.05M
59.09M
2026-03
×